Pancreatic Cancer Research

ResearcherAnhui University of Science and TechnologyActive in the last 2 years

Xin Xing

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-4766-4926; OpenAlex author ID A5101609514. Sources: OpenAlex.

Their work

Papers
7 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
24
Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: 3 papers · 2022: none · 2023: none · 2024: 1 paper · 2025: 2 papers

Papers 7

  1. B4GALT5 inhibits CD8+ T-cell response by downregulating MHC-I level through ERAD pathway in PDAC. Co-author DOI 10.1136/jitc-2024-010908↗
  2. OASL promotes immune evasion in pancreatic ductal adenocarcinoma by enhancing autolysosome-mediated degradation of MHC-I. Co-author DOI 10.7150/thno.103494↗
  3. Identification of a novel m6A-related lncRNAs signature and immunotherapeutic drug sensitivity in pancreatic adenocarcinoma. Last author DOI 10.1186/s12885-024-11885-8↗
  4. Single-cell RNA sequencing reveals that targeting HSP90 suppresses PDAC progression by restraining mitochondrial bioenergetics. Co-author DOI 10.1038/s41389-021-00311-4↗
  5. FUBP1 mediates the growth and metastasis through TGFβ/Smad signaling in pancreatic adenocarcinoma. Co-author DOI 10.3892/ijmm.2021.4899↗
  6. Deciphering the genomic and lncRNA landscapes of aerobic glycolysis identifies potential therapeutic targets in pancreatic cancer. Co-author DOI 10.7150/ijbs.49243↗
  7. Integrated expression profiling of potassium channels identifys KCNN4 as a prognostic biomarker of pancreatic cancer. Co-author DOI 10.1016/j.bbrc.2017.10.072↗

Closest collaborators

The 24 strongest of 24 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Zhigang Zhang · 5 shared papers, 2017–2025 · strength 0.72
  2. Aziguli Tulamaiti · 3 shared papers, 2024–2025 · strength 0.64
  3. Xia-Qing Li · 3 shared papers, 2024–2025 · strength 0.64
  4. Li-Peng Hu · 4 shared papers, 2017–2025 · strength 0.51
  5. Shu‐Heng Jiang · 4 shared papers, 2017–2025 · strength 0.51
  6. Xueli Zhang · 2 shared papers, 2021–2025 · strength 0.32
  7. Dong‐Xue Li · 1 shared paper, 2025 · strength 0.22
  8. Xueli Zhang · 1 shared paper, 2025 · strength 0.22
  9. Xiaomei Yang · 1 shared paper, 2025 · strength 0.22
  10. Xu Wang · 2 shared papers, 2021 · strength 0.22
  11. Qin Yang · 2 shared papers, 2021 · strength 0.22
  12. Yongwei Sun · 2 shared papers, 2017–2021 · strength 0.19
  13. Yue Zhang · 1 shared paper, 2021 · strength 0.14
  14. Xingxing Zhang · 1 shared paper, 2021 · strength 0.14
  15. Rongkun Li · 1 shared paper, 2021 · strength 0.11
  16. Yongsheng Jiang · 1 shared paper, 2021 · strength 0.11
  17. Lili Zhu · 1 shared paper, 2021 · strength 0.11
  18. Qing Li · 1 shared paper, 2021 · strength 0.10
  19. Dejun Liu · 1 shared paper, 2021 · strength 0.10
  20. Minwei Yang · 1 shared paper, 2021 · strength 0.10
  21. Kaixia Zhou · 1 shared paper, 2021 · strength 0.10
  22. Yan‐Miao Huo · 1 shared paper, 2021 · strength 0.10
  23. Linli Yao · 1 shared paper, 2021 · strength 0.10
  24. Jian‐Yu Yang · 1 shared paper, 2017 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.